2021
DOI: 10.1038/s41557-021-00829-5
|View full text |Cite
|
Sign up to set email alerts
|

A mating mechanism to generate diversity for the Darwinian selection of DNA-encoded synthetic molecules

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
20
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 28 publications
(24 citation statements)
references
References 69 publications
0
20
0
Order By: Relevance
“…[108][109][110][111][112][113] PNA-small-molecule (especially glycans) conjugates have been used to tailor the valency, distance, and geometry of the ligands in the assembly. 112,155,156 In principle, many of the PNA-encoded systems could be adapted to be dynamic and lead to novel applications; 39 however, so far, the examples are scarce. In 2017, the Winssinger group introduced dynamic hybridization in a multivalent assembly of PNA-glycan conjugates, which achieved an exceptional affinity gain and inhibitory activity against bacteria lectins, as compared with the monovalent ligands (Fig.…”
Section: Non-fragment-based Dna-encoded Dynamic Librarymentioning
confidence: 99%
“…[108][109][110][111][112][113] PNA-small-molecule (especially glycans) conjugates have been used to tailor the valency, distance, and geometry of the ligands in the assembly. 112,155,156 In principle, many of the PNA-encoded systems could be adapted to be dynamic and lead to novel applications; 39 however, so far, the examples are scarce. In 2017, the Winssinger group introduced dynamic hybridization in a multivalent assembly of PNA-glycan conjugates, which achieved an exceptional affinity gain and inhibitory activity against bacteria lectins, as compared with the monovalent ligands (Fig.…”
Section: Non-fragment-based Dna-encoded Dynamic Librarymentioning
confidence: 99%
“…Although having been used in early studies, 2 , 35 DELs encoded with single-stranded DNAs (ssDELs) are less abundant and they are often prepared with special encoding methods, such as DNA-templated synthesis (DTS), 36 DNA routing, 37 and DNA-directed assembly. 38 , 39 ssDNAs can also be used to assemble the encoded self-assembling chemical (ESAC) libraries 40 42 and DNA-encoded dynamic libraries. 43 51 Moreover, ssDELs are amendable to a number of selection methods suitable for nonimmobilized proteins, such as the interaction determination using unpurified proteins (IDUP), 52 , 53 the cross-linking-based methods, 54 60 and the selections against membrane proteins on/inside live cells ( Figure 1 c).…”
Section: Introductionmentioning
confidence: 99%
“…In fact, today, the majority of DELs are encoded with dsDNA tags. Although having been used in early studies, , DELs encoded with single-stranded DNAs (ssDELs) are less abundant and they are often prepared with special encoding methods, such as DNA-templated synthesis (DTS), DNA routing, and DNA-directed assembly. , ssDNAs can also be used to assemble the encoded self-assembling chemical (ESAC) libraries and DNA-encoded dynamic libraries. Moreover, ssDELs are amendable to a number of selection methods suitable for nonimmobilized proteins, such as the interaction determination using unpurified proteins (IDUP), , the cross-linking-based methods, and the selections against membrane proteins on/inside live cells (Figure c). , In these methods, the ssDNA tag provides a site for hybridization with an additional DNA to covalently connect with the target upon binding. These methods may expand the target scope of DELs to more complex targets in a more biologically relevant environment. , In addition, a recent report showed that ssDELs had higher enrichment folds than dsDELs, especially for low- to moderate-affinity binders .…”
Section: Introductionmentioning
confidence: 99%
“…Attracted by the DEL's cost and time efficiency, both academia and pharmaceutical companies have advanced DEL in terms of synthetic methodology and selection strategy. [18][19][20][21][22][23][24][25][26][27][28][29][30][31] Currently, although very few drug candidates in late-stage clinical trials stemmed from DEL, such as the soluble epoxide hydrolase (sEH) inhibitor GSK2256294 and the receptor-interacting protein (RIP1) kinase inhibitor GSK2982772, [32][33][34][35] DELs have shown their potential in high-throughput discovery of preliminary bioactive hits for dened targets, which might lead to the development of bioactive compounds or probes with structural optimization.…”
Section: Introductionmentioning
confidence: 99%